{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:23:59Z","timestamp":1791217439390,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,11,18]],"date-time":"2006-11-18T00:00:00Z","timestamp":1163808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,11,18]],"date-time":"2006-11-18T00:00:00Z","timestamp":1163808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s00280-006-0371-x","type":"journal-article","created":{"date-parts":[[2006,11,17]],"date-time":"2006-11-17T14:44:07Z","timestamp":1163774647000},"page":"391-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers"],"prefix":"10.1007","volume":"60","author":[{"given":"D. Ross","family":"Camidge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Smethurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Growcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel C.","family":"Barrass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Febbraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Swaisland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,11,18]]},"reference":[{"key":"371_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/sj.bjc.6602229","volume":"92","author":"C Benson","year":"2005","unstructured":"Benson C, Kaye S, Workman P, Garrett M, Walton M, deBono J (2005) Clinical anticancer drug development: targeting the cyclin-dependent kinases. Br J Cancer 92:7\u201312","journal-title":"Br J Cancer"},{"issue":"16","key":"371_CR2","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1200\/JCO.2004.12.007","volume":"22","author":"J Dupont","year":"2004","unstructured":"Dupont J, Bienvenu B, Aghajanian C, Pezzulli S, Sabbatini P, Vongphrachanh P, Chang C, Perkell C, Ng K, Passe S, Breimer L, Zhi J, DeMario M, Spriggs D, Soignet SL (2004) Phase I and pharmacokinetic study of the novel oral cell-cycle inhibitor Ro 31\u20137453 in patients with advanced solid tumors. J Clin Oncol 22(16):3366\u20133374","journal-title":"J Clin Oncol"},{"issue":"6","key":"371_CR3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1517\/13543784.12.6.955","volume":"12","author":"PM Fischer","year":"2003","unstructured":"Fischer PM, Gianella-Borradori A (2003) CDK inhibitors in clinical development for the treatment of cancer. Expert Opin Investig Drugs 12(6):955\u2013970","journal-title":"Expert Opin Investig Drugs"},{"key":"371_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1517\/13543784.14.4.457","volume":"14","author":"PM Fischer","year":"2005","unstructured":"Fischer PM, Gianella-Borradori A (2005) Recent progress in the discovery and development of cyclin-dependent kinase inhibitiors. Expert Opin Investig Drugs 14:457\u2013477","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"371_CR5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF03402115","volume":"6","author":"Gorgoulis VG","year":"2000","unstructured":"Gorgoulis VG, Zacharatos P, Kotsinas A, Mariatos G, Liloglou T, Vogiatzi T, Foukas P, Rassidakis G, Garinis G, Ioannides T, Zoumpourlis V, Bramis J, Michail PO, Asimacopoulos PJ, Field JK, Kittas C (2000) Altered expression of the cell cycle regulatory molecules pRb, p53 and MDM2 exert a synergetic effect on tumor growth and chromosomal instability in non-small cell lung carcinomas (NSCLCs). Mol Med 6(3):208\u2013237","journal-title":"Mol Med"},{"issue":"2\u20133","key":"371_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0169-5002(01)00196-9","volume":"33","author":"M Gugger","year":"2001","unstructured":"Gugger M, Kappeler A, Vonlanthen S, Altermatt HJ, Ris HB, Lardinois D, Borner MM, Heighway J, Betticher DC (2001) Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours. Lung Cancer 33(2\u20133):229\u2013239","journal-title":"Lung Cancer"},{"issue":"7","key":"371_CR7","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.humpath.2004.01.019","volume":"35","author":"MA Le Frere-Belda","year":"2004","unstructured":"Le Frere-Belda MA, Gil Diez de Medina S, Daher A, Martin N, Albaud B, Heudes D, Abbou CC, Thiery JP, Zafrani ES, Radvanyi F, Chopin D (2004) Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status. Hum Pathol 35(7):817\u2013824","journal-title":"Hum Pathol"},{"key":"371_CR8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/MCB.18.2.753","volume":"18","author":"AS Lundberg","year":"1998","unstructured":"Lundberg AS, Weinberg RA (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol 18:753\u2013761","journal-title":"Mol. Cell. Biol"},{"issue":"5","key":"371_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1053\/j.seminoncol.2005.07.009","volume":"32","author":"M Macalusmo","year":"2005","unstructured":"Macalusmo M, Montanari M, Cinti C, Giordano A (2005) Modulation of cell-cycle components by genetic and epigenetic events. Semin Oncol 32(5):452\u2013457","journal-title":"Semin Oncol"},{"issue":"11","key":"371_CR10","first-page":"3481","volume":"7","author":"M Omura-Minamisawa","year":"2001","unstructured":"Omura-Minamisawa M, Mitchell B. Diccianni MB, Chang RC, Batova A, Bridgeman LJ, Schiff J, Cohn SL, London WB, Yu AL (2001) p16\/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease. Clin Cancer Res 7(11):3481\u20133490","journal-title":"Clin Cancer Res"},{"key":"371_CR11","doi-asserted-by":"publisher","first-page":"9408","DOI":"10.1200\/JCO.2005.01.5594","volume":"23","author":"GK Schwartz","year":"2005","unstructured":"Schwartz GK, Shah MA (2005) Targetting the cell cycle: a new approach to cancer therapy. J Clin Oncol 23:9408\u20139421","journal-title":"J Clin Oncol"},{"issue":"3","key":"371_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1023\/A:1006353008903","volume":"17","author":"PM Senderowicz","year":"1999","unstructured":"Senderowicz PM (1999) Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials. Invest New Drugs 17(3):313\u2013320","journal-title":"Invest New Drugs"},{"issue":"4\u20136","key":"371_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000086970","volume":"68","author":"S Soni","year":"2005","unstructured":"Soni S, Kaur J, Kumar A, Chakravarti N, Mathur M, Bahadur S, Shukla NK, Deo SV, Ralhan R (2005) Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Oncology 68(4\u20136):314\u2013325","journal-title":"Oncology"},{"issue":"8","key":"371_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1359-6349(03)80014-9","volume":"1","author":"C Wheeler","year":"2003","unstructured":"Wheeler C, Stephens T, Byth K et al (2003) Novel approaches in oncology at AstraZeneca. Eur J Cancer Suppl 1(8):3\u20138","journal-title":"Eur J Cancer Suppl"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-006-0371-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-006-0371-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-006-0371-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-006-0371-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T19:26:23Z","timestamp":1652729183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-006-0371-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,18]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["371"],"URL":"https:\/\/doi.org\/10.1007\/s00280-006-0371-x","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,18]]},"assertion":[{"value":"16 June 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}